Peter F A Mulders Selected Research

Prednisone (Sone)

7/2017	Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone.
1/2017	Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
10/2015	Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.
2/2015	Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
11/2014	Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
1/2013	Abiraterone in metastatic prostate cancer without previous chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter F A Mulders Research Topics

Disease

44	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 02/2002
35	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2007
32	Neoplasms (Cancer) 01/2023 - 11/2002
8	Neoplasm Metastasis (Metastasis) 07/2018 - 05/2009
3	Kidney Neoplasms (Kidney Cancer) 01/2016 - 10/2011
3	Disease Progression 01/2015 - 09/2005
2	Pain (Aches) 03/2024 - 11/2014
2	Margins of Excision 02/2019 - 08/2015
2	Lymphatic Metastasis 07/2017 - 05/2009
2	Carcinoma (Carcinomatosis) 01/2017 - 01/2016
2	Heart Diseases (Heart Disease) 11/2015 - 02/2015
2	Cancer Pain 10/2015 - 01/2013
1	Postoperative Pain 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017
1	Neoplasm Micrometastasis 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Flatulence 01/2016
1	Diarrhea 01/2016
1	Colic (Abdominal Cramps) 01/2016
1	Heartburn (Pyrosis) 01/2016
1	Duodenitis 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Hypertension (High Blood Pressure) 02/2015
1	Necrosis 02/2015
1	Seizures (Absence Seizure) 01/2015
1	Fatigue 01/2015
1	Nausea 01/2015

Drug/Important Bio-Agent (IBA)

17	Carbonic Anhydrase IXIBA 05/2022 - 09/2003
15	G250 monoclonal antibodyIBA 01/2023 - 09/2003
12	Abiraterone AcetateIBA 07/2018 - 01/2013
11	Monoclonal AntibodiesIBA 01/2018 - 09/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
10	AntigensIBA 01/2017 - 07/2003
9	Prostate-Specific Antigen (Semenogelase)IBA 12/2020 - 02/2007
6	Sunitinib (Sutent)FDA Link 10/2022 - 01/2009
6	Prednisone (Sone)FDA LinkGeneric 07/2017 - 01/2013
6	AntibodiesIBA 01/2016 - 07/2003
6	Sorafenib (BAY 43-9006)FDA Link 03/2014 - 01/2009
5	Radioisotopes (Radionuclides)IBA 05/2022 - 09/2003
5	AndrogensIBA 01/2017 - 01/2013
5	Tyrosine Kinase InhibitorsIBA 01/2016 - 04/2008
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2014
4	enzalutamideIBA 07/2018 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 10/2017 - 07/2003
3	LutetiumIBA 01/2016 - 09/2013
3	Docetaxel (Taxotere)FDA Link 01/2015 - 05/2014
2	Fluorescent Dyes (Fluorescent Probes)IBA 10/2017 - 01/2016
2	Dutasteride (Avodart)FDA Link 01/2016 - 11/2009
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 11/2010
2	Indium-111IBA 01/2016 - 06/2013
2	Opiate AlkaloidsIBA 10/2015 - 01/2013
2	Testosterone (Sustanon)FDA Link 01/2015 - 07/2013
2	abirateroneIBA 11/2014 - 01/2013
2	Interleukin-2 (IL2)IBA 02/2010 - 11/2002
2	Dihydrotachysterol (AT 10)IBA 12/2009 - 02/2009
1	Analgesics (Analgesic Drugs)IBA 03/2024
1	Lutetium-177IBA 05/2022
1	Actinium-225IBA 05/2022
1	Immunoconjugates (Immunoconjugate)IBA 05/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2018
1	Denosumab FDA Link 07/2018
1	Radium-223IBA 07/2018
1	Diphosphonates (Bisphosphonates)IBA 07/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Folate Receptor 1IBA 10/2017
1	farletuzumabIBA 10/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2017
1	AcidsIBA 01/2017
1	SuspensionsIBA 01/2017
1	labetuzumabIBA 01/2017
1	NivolumabIBA 04/2016
1	Everolimus FDA Link 04/2016
1	bicalutamide (Casodex)FDA LinkGeneric 01/2016
1	Capsules (Microcapsules)IBA 01/2016
1	Pentetic Acid (DTPA)FDA LinkGeneric 08/2015
1	Alanine Transaminase (SGPT)IBA 02/2015
1	Hormones (Hormone)IBA 01/2015
1	Coloring Agents (Dyes)IBA 06/2014
1	N 30IBA 03/2014

Therapy/Procedure

19	Therapeutics 10/2022 - 09/2003
16	Castration 07/2018 - 01/2013
10	Drug Therapy (Chemotherapy) 07/2017 - 11/2007
8	Nephrectomy 02/2019 - 02/2002
7	Radioimmunotherapy 10/2022 - 09/2005
6	Immunotherapy 01/2019 - 02/2002
3	Aftercare (After-Treatment) 01/2017 - 01/2012
2	Life Support Care 10/2015 - 11/2014
2	Neoadjuvant Therapy 07/2011 - 11/2010
1	Length of Stay 03/2024
1	Prostatectomy (Retropubic Prostatectomy) 11/2020
1	Cryosurgery 01/2020
1	Cystectomy 01/2019
1	Conservative Treatment 08/2018
1	Intravenous Injections 01/2017
1	Retreatment 01/2016
1	Duration of Therapy 01/2016
1	Drug Tapering 11/2015
1	Computer-Assisted Surgery (Image Guided Surgery) 08/2015